Paychex, Inc. coverage reinstated with neutral rating and $120 price objective
PAYX•BofA Global Research reinstated coverage of Paychex, Inc. with a neutral rating and a $120 price objective.
Related News

Reinsurance Group of America target price raised to $325 from $236
RGA•

Waystar wins largest-ever client deal with WVU Medicine
WAY•

BofA Global Research initiates coverage of Viridian Therapeutics with buy rating; price objective $47
VRDN•

Expeditors International of Washington: UBS raises target price to $252 from $245
EXPD•

UBS cuts Lowe's Companies' target price to $269 from $275
LOW•